ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell Therapy CDMO Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-35T14289
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cell Therapy CDMO Market Research Report 2023
BUY CHAPTERS

Global Cell Therapy CDMO Market Research Report 2025

Code: QYRE-Auto-35T14289
Report
January 2025
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Charles River
The Discovery Labs
BioCentriq
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith Co., Ltd.
Thermogenesis
Anemocyte Srl
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio

Cell Therapy CDMO Market

The global market for Cell Therapy CDMO was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Cell Therapy CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell Therapy CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cell Therapy CDMO in Commercial is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cell Therapy CDMO include Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO, Cell Therapies, AGC Biologics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell Therapy CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Therapy CDMO.
The Cell Therapy CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell Therapy CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Therapy CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cell Therapy CDMO Market Report

Report Metric Details
Report Name Cell Therapy CDMO Market
Segment by Type
Segment by Application
  • Commercial
  • Academic Research
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO, Cell Therapies, AGC Biologics, Cytiva, Helixmith, ThermoGenesis, Anemocyte, Thermo Fisher Scientific, CBM, Bio Elpida, Genezen, CCRM, RoslinCT, GenScript ProBio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell Therapy CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cell Therapy CDMO Market report?

Ans: The main players in the Cell Therapy CDMO Market are Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO, Cell Therapies, AGC Biologics, Cytiva, Helixmith, ThermoGenesis, Anemocyte, Thermo Fisher Scientific, CBM, Bio Elpida, Genezen, CCRM, RoslinCT, GenScript ProBio

What are the Application segmentation covered in the Cell Therapy CDMO Market report?

Ans: The Applications covered in the Cell Therapy CDMO Market report are Commercial, Academic Research, Others

What are the Type segmentation covered in the Cell Therapy CDMO Market report?

Ans: The Types covered in the Cell Therapy CDMO Market report are Stem Cell, Non-Stem Cell

Recommended Reports

Cell Therapy Market

CDMO Services

Stem Cell Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stem Cell
1.2.3 Non-Stem Cell
1.3 Market by Application
1.3.1 Global Cell Therapy CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy CDMO Market Perspective (2020-2031)
2.2 Global Cell Therapy CDMO Growth Trends by Region
2.2.1 Global Cell Therapy CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell Therapy CDMO Historic Market Size by Region (2020-2025)
2.2.3 Cell Therapy CDMO Forecasted Market Size by Region (2026-2031)
2.3 Cell Therapy CDMO Market Dynamics
2.3.1 Cell Therapy CDMO Industry Trends
2.3.2 Cell Therapy CDMO Market Drivers
2.3.3 Cell Therapy CDMO Market Challenges
2.3.4 Cell Therapy CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Therapy CDMO Players by Revenue
3.1.1 Global Top Cell Therapy CDMO Players by Revenue (2020-2025)
3.1.2 Global Cell Therapy CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell Therapy CDMO Revenue
3.4 Global Cell Therapy CDMO Market Concentration Ratio
3.4.1 Global Cell Therapy CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy CDMO Revenue in 2024
3.5 Global Key Players of Cell Therapy CDMO Head office and Area Served
3.6 Global Key Players of Cell Therapy CDMO, Product and Application
3.7 Global Key Players of Cell Therapy CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy CDMO Breakdown Data by Type
4.1 Global Cell Therapy CDMO Historic Market Size by Type (2020-2025)
4.2 Global Cell Therapy CDMO Forecasted Market Size by Type (2026-2031)
5 Cell Therapy CDMO Breakdown Data by Application
5.1 Global Cell Therapy CDMO Historic Market Size by Application (2020-2025)
5.2 Global Cell Therapy CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell Therapy CDMO Market Size (2020-2031)
6.2 North America Cell Therapy CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell Therapy CDMO Market Size by Country (2020-2025)
6.4 North America Cell Therapy CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Therapy CDMO Market Size (2020-2031)
7.2 Europe Cell Therapy CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell Therapy CDMO Market Size by Country (2020-2025)
7.4 Europe Cell Therapy CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy CDMO Market Size (2020-2031)
8.2 Asia-Pacific Cell Therapy CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell Therapy CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell Therapy CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Therapy CDMO Market Size (2020-2031)
9.2 Latin America Cell Therapy CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell Therapy CDMO Market Size by Country (2020-2025)
9.4 Latin America Cell Therapy CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy CDMO Market Size (2020-2031)
10.2 Middle East & Africa Cell Therapy CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell Therapy CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell Therapy CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Cell Therapy CDMO Introduction
11.1.4 Charles River Revenue in Cell Therapy CDMO Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 The Discovery Labs
11.2.1 The Discovery Labs Company Details
11.2.2 The Discovery Labs Business Overview
11.2.3 The Discovery Labs Cell Therapy CDMO Introduction
11.2.4 The Discovery Labs Revenue in Cell Therapy CDMO Business (2020-2025)
11.2.5 The Discovery Labs Recent Development
11.3 BIOCENTRIQ
11.3.1 BIOCENTRIQ Company Details
11.3.2 BIOCENTRIQ Business Overview
11.3.3 BIOCENTRIQ Cell Therapy CDMO Introduction
11.3.4 BIOCENTRIQ Revenue in Cell Therapy CDMO Business (2020-2025)
11.3.5 BIOCENTRIQ Recent Development
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Details
11.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Introduction
11.4.4 FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy CDMO Business (2020-2025)
11.4.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.5 Exothera
11.5.1 Exothera Company Details
11.5.2 Exothera Business Overview
11.5.3 Exothera Cell Therapy CDMO Introduction
11.5.4 Exothera Revenue in Cell Therapy CDMO Business (2020-2025)
11.5.5 Exothera Recent Development
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Details
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec Cell Therapy CDMO Introduction
11.6.4 WuXi AppTec Revenue in Cell Therapy CDMO Business (2020-2025)
11.6.5 WuXi AppTec Recent Development
11.7 Pharmaron
11.7.1 Pharmaron Company Details
11.7.2 Pharmaron Business Overview
11.7.3 Pharmaron Cell Therapy CDMO Introduction
11.7.4 Pharmaron Revenue in Cell Therapy CDMO Business (2020-2025)
11.7.5 Pharmaron Recent Development
11.8 OBiO
11.8.1 OBiO Company Details
11.8.2 OBiO Business Overview
11.8.3 OBiO Cell Therapy CDMO Introduction
11.8.4 OBiO Revenue in Cell Therapy CDMO Business (2020-2025)
11.8.5 OBiO Recent Development
11.9 Cell Therapies
11.9.1 Cell Therapies Company Details
11.9.2 Cell Therapies Business Overview
11.9.3 Cell Therapies Cell Therapy CDMO Introduction
11.9.4 Cell Therapies Revenue in Cell Therapy CDMO Business (2020-2025)
11.9.5 Cell Therapies Recent Development
11.10 AGC Biologics
11.10.1 AGC Biologics Company Details
11.10.2 AGC Biologics Business Overview
11.10.3 AGC Biologics Cell Therapy CDMO Introduction
11.10.4 AGC Biologics Revenue in Cell Therapy CDMO Business (2020-2025)
11.10.5 AGC Biologics Recent Development
11.11 Cytiva
11.11.1 Cytiva Company Details
11.11.2 Cytiva Business Overview
11.11.3 Cytiva Cell Therapy CDMO Introduction
11.11.4 Cytiva Revenue in Cell Therapy CDMO Business (2020-2025)
11.11.5 Cytiva Recent Development
11.12 Helixmith
11.12.1 Helixmith Company Details
11.12.2 Helixmith Business Overview
11.12.3 Helixmith Cell Therapy CDMO Introduction
11.12.4 Helixmith Revenue in Cell Therapy CDMO Business (2020-2025)
11.12.5 Helixmith Recent Development
11.13 ThermoGenesis
11.13.1 ThermoGenesis Company Details
11.13.2 ThermoGenesis Business Overview
11.13.3 ThermoGenesis Cell Therapy CDMO Introduction
11.13.4 ThermoGenesis Revenue in Cell Therapy CDMO Business (2020-2025)
11.13.5 ThermoGenesis Recent Development
11.14 Anemocyte
11.14.1 Anemocyte Company Details
11.14.2 Anemocyte Business Overview
11.14.3 Anemocyte Cell Therapy CDMO Introduction
11.14.4 Anemocyte Revenue in Cell Therapy CDMO Business (2020-2025)
11.14.5 Anemocyte Recent Development
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Details
11.15.2 Thermo Fisher Scientific Business Overview
11.15.3 Thermo Fisher Scientific Cell Therapy CDMO Introduction
11.15.4 Thermo Fisher Scientific Revenue in Cell Therapy CDMO Business (2020-2025)
11.15.5 Thermo Fisher Scientific Recent Development
11.16 CBM
11.16.1 CBM Company Details
11.16.2 CBM Business Overview
11.16.3 CBM Cell Therapy CDMO Introduction
11.16.4 CBM Revenue in Cell Therapy CDMO Business (2020-2025)
11.16.5 CBM Recent Development
11.17 Bio Elpida
11.17.1 Bio Elpida Company Details
11.17.2 Bio Elpida Business Overview
11.17.3 Bio Elpida Cell Therapy CDMO Introduction
11.17.4 Bio Elpida Revenue in Cell Therapy CDMO Business (2020-2025)
11.17.5 Bio Elpida Recent Development
11.18 Genezen
11.18.1 Genezen Company Details
11.18.2 Genezen Business Overview
11.18.3 Genezen Cell Therapy CDMO Introduction
11.18.4 Genezen Revenue in Cell Therapy CDMO Business (2020-2025)
11.18.5 Genezen Recent Development
11.19 CCRM
11.19.1 CCRM Company Details
11.19.2 CCRM Business Overview
11.19.3 CCRM Cell Therapy CDMO Introduction
11.19.4 CCRM Revenue in Cell Therapy CDMO Business (2020-2025)
11.19.5 CCRM Recent Development
11.20 RoslinCT
11.20.1 RoslinCT Company Details
11.20.2 RoslinCT Business Overview
11.20.3 RoslinCT Cell Therapy CDMO Introduction
11.20.4 RoslinCT Revenue in Cell Therapy CDMO Business (2020-2025)
11.20.5 RoslinCT Recent Development
11.21 GenScript ProBio
11.21.1 GenScript ProBio Company Details
11.21.2 GenScript ProBio Business Overview
11.21.3 GenScript ProBio Cell Therapy CDMO Introduction
11.21.4 GenScript ProBio Revenue in Cell Therapy CDMO Business (2020-2025)
11.21.5 GenScript ProBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Charles River
The Discovery Labs
BioCentriq
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith Co., Ltd.
Thermogenesis
Anemocyte Srl
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
List of Tables
 Table 1. Global Cell Therapy CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Stem Cell
 Table 3. Key Players of Non-Stem Cell
 Table 4. Global Cell Therapy CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Cell Therapy CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cell Therapy CDMO Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Cell Therapy CDMO Market Share by Region (2020-2025)
 Table 8. Global Cell Therapy CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Cell Therapy CDMO Market Share by Region (2026-2031)
 Table 10. Cell Therapy CDMO Market Trends
 Table 11. Cell Therapy CDMO Market Drivers
 Table 12. Cell Therapy CDMO Market Challenges
 Table 13. Cell Therapy CDMO Market Restraints
 Table 14. Global Cell Therapy CDMO Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Cell Therapy CDMO Market Share by Players (2020-2025)
 Table 16. Global Top Cell Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CDMO as of 2024)
 Table 17. Ranking of Global Top Cell Therapy CDMO Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Cell Therapy CDMO Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Cell Therapy CDMO, Headquarters and Area Served
 Table 20. Global Key Players of Cell Therapy CDMO, Product and Application
 Table 21. Global Key Players of Cell Therapy CDMO, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Cell Therapy CDMO Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Cell Therapy CDMO Revenue Market Share by Type (2020-2025)
 Table 25. Global Cell Therapy CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Cell Therapy CDMO Revenue Market Share by Type (2026-2031)
 Table 27. Global Cell Therapy CDMO Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Cell Therapy CDMO Revenue Market Share by Application (2020-2025)
 Table 29. Global Cell Therapy CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Cell Therapy CDMO Revenue Market Share by Application (2026-2031)
 Table 31. North America Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Cell Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Cell Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Cell Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Cell Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Cell Therapy CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Cell Therapy CDMO Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Cell Therapy CDMO Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Cell Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Cell Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Cell Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Cell Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Charles River Company Details
 Table 47. Charles River Business Overview
 Table 48. Charles River Cell Therapy CDMO Product
 Table 49. Charles River Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 50. Charles River Recent Development
 Table 51. The Discovery Labs Company Details
 Table 52. The Discovery Labs Business Overview
 Table 53. The Discovery Labs Cell Therapy CDMO Product
 Table 54. The Discovery Labs Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 55. The Discovery Labs Recent Development
 Table 56. BIOCENTRIQ Company Details
 Table 57. BIOCENTRIQ Business Overview
 Table 58. BIOCENTRIQ Cell Therapy CDMO Product
 Table 59. BIOCENTRIQ Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 60. BIOCENTRIQ Recent Development
 Table 61. FUJIFILM Diosynth Biotechnologies Company Details
 Table 62. FUJIFILM Diosynth Biotechnologies Business Overview
 Table 63. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product
 Table 64. FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 65. FUJIFILM Diosynth Biotechnologies Recent Development
 Table 66. Exothera Company Details
 Table 67. Exothera Business Overview
 Table 68. Exothera Cell Therapy CDMO Product
 Table 69. Exothera Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 70. Exothera Recent Development
 Table 71. WuXi AppTec Company Details
 Table 72. WuXi AppTec Business Overview
 Table 73. WuXi AppTec Cell Therapy CDMO Product
 Table 74. WuXi AppTec Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 75. WuXi AppTec Recent Development
 Table 76. Pharmaron Company Details
 Table 77. Pharmaron Business Overview
 Table 78. Pharmaron Cell Therapy CDMO Product
 Table 79. Pharmaron Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 80. Pharmaron Recent Development
 Table 81. OBiO Company Details
 Table 82. OBiO Business Overview
 Table 83. OBiO Cell Therapy CDMO Product
 Table 84. OBiO Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 85. OBiO Recent Development
 Table 86. Cell Therapies Company Details
 Table 87. Cell Therapies Business Overview
 Table 88. Cell Therapies Cell Therapy CDMO Product
 Table 89. Cell Therapies Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 90. Cell Therapies Recent Development
 Table 91. AGC Biologics Company Details
 Table 92. AGC Biologics Business Overview
 Table 93. AGC Biologics Cell Therapy CDMO Product
 Table 94. AGC Biologics Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 95. AGC Biologics Recent Development
 Table 96. Cytiva Company Details
 Table 97. Cytiva Business Overview
 Table 98. Cytiva Cell Therapy CDMO Product
 Table 99. Cytiva Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 100. Cytiva Recent Development
 Table 101. Helixmith Company Details
 Table 102. Helixmith Business Overview
 Table 103. Helixmith Cell Therapy CDMO Product
 Table 104. Helixmith Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 105. Helixmith Recent Development
 Table 106. ThermoGenesis Company Details
 Table 107. ThermoGenesis Business Overview
 Table 108. ThermoGenesis Cell Therapy CDMO Product
 Table 109. ThermoGenesis Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 110. ThermoGenesis Recent Development
 Table 111. Anemocyte Company Details
 Table 112. Anemocyte Business Overview
 Table 113. Anemocyte Cell Therapy CDMO Product
 Table 114. Anemocyte Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 115. Anemocyte Recent Development
 Table 116. Thermo Fisher Scientific Company Details
 Table 117. Thermo Fisher Scientific Business Overview
 Table 118. Thermo Fisher Scientific Cell Therapy CDMO Product
 Table 119. Thermo Fisher Scientific Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 120. Thermo Fisher Scientific Recent Development
 Table 121. CBM Company Details
 Table 122. CBM Business Overview
 Table 123. CBM Cell Therapy CDMO Product
 Table 124. CBM Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 125. CBM Recent Development
 Table 126. Bio Elpida Company Details
 Table 127. Bio Elpida Business Overview
 Table 128. Bio Elpida Cell Therapy CDMO Product
 Table 129. Bio Elpida Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 130. Bio Elpida Recent Development
 Table 131. Genezen Company Details
 Table 132. Genezen Business Overview
 Table 133. Genezen Cell Therapy CDMO Product
 Table 134. Genezen Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 135. Genezen Recent Development
 Table 136. CCRM Company Details
 Table 137. CCRM Business Overview
 Table 138. CCRM Cell Therapy CDMO Product
 Table 139. CCRM Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 140. CCRM Recent Development
 Table 141. RoslinCT Company Details
 Table 142. RoslinCT Business Overview
 Table 143. RoslinCT Cell Therapy CDMO Product
 Table 144. RoslinCT Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 145. RoslinCT Recent Development
 Table 146. GenScript ProBio Company Details
 Table 147. GenScript ProBio Business Overview
 Table 148. GenScript ProBio Cell Therapy CDMO Product
 Table 149. GenScript ProBio Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 150. GenScript ProBio Recent Development
 Table 151. Research Programs/Design for This Report
 Table 152. Key Data Information from Secondary Sources
 Table 153. Key Data Information from Primary Sources
 Table 154. Authors List of This Report


List of Figures
 Figure 1. Cell Therapy CDMO Picture
 Figure 2. Global Cell Therapy CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cell Therapy CDMO Market Share by Type: 2024 VS 2031
 Figure 4. Stem Cell Features
 Figure 5. Non-Stem Cell Features
 Figure 6. Global Cell Therapy CDMO Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cell Therapy CDMO Market Share by Application: 2024 VS 2031
 Figure 8. Commercial Case Studies
 Figure 9. Academic Research Case Studies
 Figure 10. Others Case Studies
 Figure 11. Cell Therapy CDMO Report Years Considered
 Figure 12. Global Cell Therapy CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Cell Therapy CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Cell Therapy CDMO Market Share by Region: 2024 VS 2031
 Figure 15. Global Cell Therapy CDMO Market Share by Players in 2024
 Figure 16. Global Top Cell Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CDMO as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Cell Therapy CDMO Revenue in 2024
 Figure 18. North America Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Cell Therapy CDMO Market Share by Country (2020-2031)
 Figure 20. United States Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Cell Therapy CDMO Market Share by Country (2020-2031)
 Figure 24. Germany Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Cell Therapy CDMO Market Share by Region (2020-2031)
 Figure 32. China Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Cell Therapy CDMO Market Share by Country (2020-2031)
 Figure 40. Mexico Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Cell Therapy CDMO Market Share by Country (2020-2031)
 Figure 44. Turkey Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Charles River Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 48. The Discovery Labs Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 49. BIOCENTRIQ Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 50. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 51. Exothera Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 52. WuXi AppTec Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 53. Pharmaron Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 54. OBiO Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 55. Cell Therapies Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 56. AGC Biologics Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 57. Cytiva Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 58. Helixmith Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 59. ThermoGenesis Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 60. Anemocyte Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 62. CBM Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 63. Bio Elpida Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 64. Genezen Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 65. CCRM Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 66. RoslinCT Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 67. GenScript ProBio Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Cell and Gene Therapy CDMO Market Research Report 2024
Global Gene Cell Therapy CDMO Market Research Report 2024
Global Cellular and Gene Therapy CDMO Market Research Report 2025
Global Cell Therapy CDMO Services Market Research Report 2025
Medical Device CDMO Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plasmid CDMO Services Market Research Report 2025
Global Cell Therapy Manufacturing Market Research Report 2025
Global CMO and CDMO biotechnology Market Research Report 2024
Global Mammalian CDMO Service Market Research Report 2024
Global Medical Device CDMO and CRO Market Research Report 2025
Global Innovative Drug CDMO Market Research Report 2024
Global Cell and Gene Therapy CDMO Services Market Research Report 2024
Global Exosome CDMO Market Research Report 2024
Global Small Molecule Innovator CDMO Market Research Report 2025
Packaging CDMO Market
Global Microbial CDMO Service Market Research Report 2024
Global Biologics Clinical Manufacturing CDMO Service Market Research Report 2024
Global Cell Therapy CMO Market Research Report 2025
Global Pharmaceutical Intermediate CDMO Market Research Report 2024
Softgel CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions